At this juncture, individuals with MCI already exhibit neuropathological hallmarks of AD, including Aβ plaques and neurofibrillary tangles of tau protein, yet their cognitive decline remains below the threshold required for a dementia diagnosis (Bruno et al., 2024; Jack et al., 2024). The gene discussed is MAPT; the disease is Alzheimer disease.